Characterization of ARL6IP5 in hepatitis C-related liver cancer [ 2013 - 2016 ]

Research Grant

Researchers: A/Pr Liang Qiao (Principal investigator) ,  Prof Jacob George (Principal investigator) ,  A/Pr Mark Douglas

Brief description The incidence and mortality from liver cancer is increasing rapidly in Australia, and hepatitis C virus infection is the most common cause. How hepatitis C leads to liver cancer is largely unknown. We identified a novel gene termed ARL6IP5 that appears to be specifically increased in liver tissue by chronic hepatitis C infection. In this project we will characterize the involvement and role of this gene in liver cancer development. Knowledge gained from this study will help us understand how hepatitis C leads to cancer.

Funding Amount $AUD 505,283.85

Funding Scheme Project Grants

Notes Standard Project Grant